Pharmacological characterization of the human melatonin Mel(1a), receptor following stable transfection into NIH3T3 cells

British Journal of Pharmacology

Volumn 124, Issue 3, 1998, Pages 485-492

  Nonno, Romolo ^a   Lucini, Valeria ^a   Pannacci, Marilou ^a   Mazzucchelli, Cristina ^a   Angeloni, Deborah ^a   Fraschini, Franco ^a   Stankov, Bojidar M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

35S GTP S binding; Efficacy; G(i) coupled receptors; Human melatonin receptor; Melatonin analogues

Indexed keywords

AMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; PARTIAL AGONIST; PERTUSSIS TOXIN; SODIUM CHLORIDE; SULFUR 35; TRYPTAMINE DERIVATIVE; UNCOUPLING PROTEIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

3T3 CELLS; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CLONING, MOLECULAR; DNA; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; MELATONIN; MICE; PERTUSSIS TOXIN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; THERMODYNAMICS; TRANSFECTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0031801678     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701860     Document Type: Article

References (39)

1. BARRETT, P., MACLEAN, A. & MORGAN, P.J. (1994). Evidence for multiple forms of melatonin receptor-G-protein complexes by solubilization and gel electrophoresis. J. Neuroendocrinol., 6, 509-515.
2. BIRNBAUMER, L., ABRAMOWITZ, J. & BROWN, A.M. (1990). Receptor-effector coupling by G proteins. Biochim. Biophys. Acta, 1031, 163-224.
3. BRADFORD, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem., 72, 248-254.
4. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
5. COSTA, T., LANG, J., GLESS, C. & HERZ, A. (1990). Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonist and sodium ions. Mol. Pharmacol., 37, 383-394.
6. COSTA, T., OGINO, Y., MUNSON, P.J., ONGUN ONARAN, H. & RODBARD, D. (1992). Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol., 41, 549-560.
7. DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
8. DOLLINS, A.B., ZHDANOVA, I.V., WURTMAN, R.J., LYNCH, H.J. & DENG, M.H. (1994). Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A., 91, 1824-1828.
9. DURANTI, E., STANKOV, B., SPADONI, G., DURANTI, A., LUCINI, V., CAPSONI, S., BIELLA, G. & FRASCHINI, F. (1992). 2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist. Life Sci., 51, 479-485.
10. FAUTECK, J.-D., LERCHL, A., BERGMANN, M., MOLLER, M., FRASCHINI, F., WITTKOVSKI, W. & STANKOV, B. (1994). The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosci. Lett., 179, 60-64.
11. FILADELFI, A.M.C. & CASTRUCCI, A.M. (1996). Serotonin and N-acetylserotonin effects on pigment cells of the toad Bufo ictericus: pharmacological characterization of melatonin receptors. Gen. Comp. Endocrinol., 103, 192-199.
12. GARRATT, P.J., JONES, R. & TOCHER, D.A. (1995). Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines. J. Med. Chem., 38, 1132-1139.
13. 2 dopamine receptors from high to low affinity for dopamine agonists. Soc. Neurosci. Abstr., 9, 31.
14. HAGAN, R.M. & OAKLEY, N.R. (1995). Melatonin comes of age? Trends Pharmacol. Sci., 16, 81-83.
15. 2+ and the βγ-subunit complex on the interactions of guanine nucleotides with G proteins. J. Biol. Chem., 262, 762-766.
16. HILF, G., GIERSHIK, P. & JAKOBS, K.H. (1989). Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem., 186, 725-731.
17. 2-adrenergic receptor by sodium. J. Biol. Chem., 265, 21590-21595.
18. +, 5′-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor-G protein precoupling. J. Pharmacol. Exp. Ther., 252, 1184-1196.
19. 35S]-GTPγS binding mediated by human muscarinic ml-m4 receptors: antagonist studies. Br. J. Pharmacol. 109, 1120-1127.
20. LEW, M.J. & ANGUS, J.A. (1995). Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci., 16, 328-337.
21. LEWY, A.J., SACK, R.L., AHMED, S., BAUER, V.K. & BLOOD, M.L. (1995). The influence of melatonin on the human circadian clock. In The Pineal Gland and Its Hormones: Fundamentals and Clinical Perspectives, ed. Fraschini, E., Reiter, R.J. & Stankov, B. Vol. 277, pp. 173-182, Nato Asi Series. New York: Plenum Press.
22. 35S]thio)triphosphate binding. Mol. Pharmacol., 44, 115-123.
23. MAZZUCCHELLI, C., PANNACCI, M., NONNO, R., LUCINI, V., FRASCHINI, F. & STANKOV, B.M. (1996). The melatonin receptor in the human brain: cloning experiments and distribution studies. Mol. Brain Res., 39, 117-126.
24. MORGAN, P.J., BARRET, P., HOWELL, H.E. & HELLIWELL, R. (1994). Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int., 24, 101-146.
25. 1 adenosine receptor/G protein coupling: Identification of a membrane protein that stabilizes the association of the receptor/G protein complex. Mol. Pharmacol., 48, 806-817.
26. NONNO, R., CAPSONI, S., LUCINI, V., MOLLER, M., FRASCHINI, F. & STANKOV, B. (1995a). Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates. J. Pineal Res., 18, 207-216.
27. 125]lodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides. Neurosci. Lett., 194, 113-116.
28. 1b melatonin receptor. Proc. Natl. Acad. Sci. U.S.A., 92, 8734-8738.
29. REPPERT, S.M., WEAVER, D.R. & EBISAWA, T. (1994). Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 13, 1177-1185.
30. SPADONI, G., BALSAMINI, C., DIAMANTINI, G., DI GIACOMO, B., TARZIA, G., MOR, M., PLAZZI, P.V., RIVARA, S., LUCINI, V., NONNO, R., PANNACCI, M., FRASCHINI, F. & STANKOV, B.M. (1997). Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study. J. Med. Chem., 40, 1990-2002.
31. SPADONI, G., STANKOV, B., DURANTI, A., BIELLA, G., LUCINI, V., SALVATORI, A. & FRASCHINl, F. (1993). 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity. J. Med. Chem., 36, 4069-4074.
32. STANKOV, B., COZZI, B., LUCINI, V., FUMAGALLI, P., SCAGLIONE, F. & FRASCHINI, F. (1991). Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. Neuroendocrinology, 53, 214-221.
33. TARZIA, G., DIAMANTINI, G., DI GIACOMO, B., SPADONI, G., ESPOSTI, D., NONNO, R., LUCINI, V., PANNACCI, M., FRASCHINI, F. & STANKOV, B.M. (1997). 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues. J. Med. Chem., 40, 2003-2010.
34. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol. Pharmacol., 45, 524-531.
35. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47, 848-854.
36. 1A receptors to adenylyl cyclase. Mol. Pharmacol., 41, 999-1007.
37. VENTER, D.P. (1997). Efficacy I: a new method for estimating relative efficacy of full agonists via a newly defined efficacy related parameter. Eur. J. Pharmacol., 320, 223-231.
38. 1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol. Pharmacol., 50, 166-174.
39. 2-dopamine receptor of the anterior pituitary gland. Mol. Pharmacol., 26, 214-227.